In a preclinical study, adagrasib-resistant KRAS/LKB1 mutant NSCLC showed enrichment in adenosquamous transition-associated genes, including Wnt4, Sfn, Aqp3, and Krt6a (24). Here, KRAS is linked to non-small cell lung carcinoma.